PRTN3 and Granuloma: Based on the updated American College of Rheumatology and European Alliance of Associations for Rheumatology (ACR/EULAR) (2022) [3] clinical classification criteria, our patient exhibited nasal involvement (+3), laboratory criteria showed a positive c-ANCA (+5) and biopsy revealed caseating and non-caseating granulomas, along with granulomatous inflammation (+2).